Dynamic Contrast- Enhanced MRI in patients with luminal Crohn’s disease

OBJECTIVES To prospectively assess dynamic contrast-enhanced (DCE-)MRI as compared to conventional sequences in patients with luminal Crohn's disease. METHODS Patients with Crohn's disease undergoing MRI and ileocolonoscopy within 1 month had DCE-MRI (3T) during intravenous contrast injection of gadobutrol, single shot fast spin echo sequence and 3D T1-weighted spoiled gradient echo sequence, a dynamic coronal 3D T1-weighted fast spoiled gradient were performed before and after gadobutrol. Maximum enhancement (ME) and initial slope of increase (ISI) were calculated for four colon segments (ascending colon+coecum, transverse colon, descending colon+sigmoid, rectum) and (neo)terminal ileum. C-reactive protein (CRP), Crohn's disease activity index (CDAI), per patient and per segment Crohn's disease endoscopic index of severity (CDEIS) and disease duration were determined. Mean values of the (DCE-)MRI parameters in each segment from each patient were compared between four disease activity groups (normal mucosa, non-ulcerative lesions, mild ulcerative and severe ulcerative disease) with Mann-Whitney test with Bonferroni adjustment. Spearman correlation coefficients were calculated for continuous variables. RESULTS Thirty-three patients were included (mean age 37 years; 23 females, median CDEIS 4.4). ME and ISI correlated weakly with segmental CDEIS (r=0.485 and r=0.206) and ME per patient correlated moderately with CDEIS (r=0.551). ME was significantly higher in segments with mild (0.378) or severe (0.388) ulcerative disease compared to normal mucosa (0.304) (p<0.001). No ulcerations were identified at conventional sequences. ME correlated with disease duration in diseased segments (r=0.492), not with CDAI and CRP. CONCLUSIONS DCE-MRI can be used as a method for detecting Crohn's disease ulcerative lesions.

[1]  R. Semelka,et al.  Magnetic resonance imaging in inflammatory bowel disease. , 1993, Journal of clinical gastroenterology.

[2]  F Kern,et al.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. , 1976, Gastroenterology.

[3]  Jaap Stoker,et al.  Retrospective comparison of magnetic resonance imaging features and histopathology in Crohn's disease patients. , 2011, European journal of radiology.

[4]  P. Bassett,et al.  MRI of small bowel Crohn’s disease: determining the reproducibility of bowel wall gadolinium enhancement measurements , 2009, European Radiology.

[5]  G. Masselli,et al.  Comparison of MR enteroclysis with MR enterography and conventional enteroclysis in patients with Crohn’s disease , 2008, European Radiology.

[6]  G. Perrone,et al.  Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn’s disease , 2008, Abdominal Imaging.

[7]  Guido Gerig,et al.  User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability , 2006, NeuroImage.

[8]  J Y Mary,et al.  Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). , 1989, Gut.

[9]  E. Neri,et al.  Dynamic MRI of the small bowel: usefulness of quantitative contrast-enhancement parameters and time–signal intensity curves for differentiating between active and inactive Crohn’s disease , 2010, Abdominal Imaging.

[10]  Stuart A. Taylor,et al.  Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. , 2009, Radiology.

[11]  Cristina Lavini,et al.  Pixel-by-pixel analysis of DCE MRI curve patterns and an illustration of its application to the imaging of the musculoskeletal system. , 2007, Magnetic resonance imaging.

[12]  F. Brahme,et al.  A comparative radiographic and pathological study of intestinal vaso-architecture in Crohn's disease and in ulcerative colitis , 1970, Gut.

[13]  Stuart A. Taylor,et al.  Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with angiogenesis and inflammation at histologic examination--pilot study. , 2009, Radiology.

[14]  Aytekin Oto,et al.  Active Crohn's Disease in the small bowel: Evaluation by diffusion weighted imaging and quantitative dynamic contrast enhanced MR imaging , 2011, Journal of magnetic resonance imaging : JMRI.

[15]  J. Ashburner,et al.  Nonlinear spatial normalization using basis functions , 1999, Human brain mapping.

[16]  Province,et al.  Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). , 1989, Gut.

[17]  P. Siersema,et al.  Dynamic contrast-enhanced MRI of the bowel wall for assessment of disease activity in Crohn's disease. , 2006, AJR. American journal of roentgenology.

[18]  Jaap Stoker,et al.  Magnetic resonance imaging for evaluation of disease activity in Crohn’s disease: a systematic review , 2009, European Radiology.

[19]  D. Hommes,et al.  Magnetic resonance imaging compared with ileocolonoscopy in evaluating disease severity in Crohn's disease. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[20]  Jordi Rimola,et al.  Magnetic resonance imaging for evaluation of Crohn's disease: Validation of parameters of severity and quantitative index of activity , 2011, Inflammatory bowel diseases.

[21]  C. Masciocchi,et al.  Assessment of inflammatory activity in Crohn’s disease by means of dynamic contrast-enhanced MRI , 2007, La radiologia medica.